Global Respiratory Drugs Market Research Report 2023

Report ID: 1898912 | Published Date: Dec 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Respiratory Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Asthma
        1.2.3 Chronic Obstructive Pulmonary Disease
        1.2.4 Idiopathic Pulmonary Fibrosis
        1.2.5 Cystic Fibrosis
    1.3 Market by Application
        1.3.1 Global Respiratory Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Ambulatory Care
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Respiratory Drugs Market Perspective (2017-2028)
    2.2 Respiratory Drugs Growth Trends by Region
        2.2.1 Respiratory Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Respiratory Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Respiratory Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Respiratory Drugs Market Dynamics
        2.3.1 Respiratory Drugs Industry Trends
        2.3.2 Respiratory Drugs Market Drivers
        2.3.3 Respiratory Drugs Market Challenges
        2.3.4 Respiratory Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Respiratory Drugs Players by Revenue
        3.1.1 Global Top Respiratory Drugs Players by Revenue (2017-2022)
        3.1.2 Global Respiratory Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Respiratory Drugs Revenue
    3.4 Global Respiratory Drugs Market Concentration Ratio
        3.4.1 Global Respiratory Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Respiratory Drugs Revenue in 2021
    3.5 Respiratory Drugs Key Players Head office and Area Served
    3.6 Key Players Respiratory Drugs Product Solution and Service
    3.7 Date of Enter into Respiratory Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Drugs Breakdown Data by Type
    4.1 Global Respiratory Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Respiratory Drugs Forecasted Market Size by Type (2023-2028)
5 Respiratory Drugs Breakdown Data by Application
    5.1 Global Respiratory Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Respiratory Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Respiratory Drugs Market Size (2017-2028)
    6.2 North America Respiratory Drugs Market Size by Country (2017-2022)
    6.3 North America Respiratory Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Respiratory Drugs Market Size (2017-2028)
    7.2 Europe Respiratory Drugs Market Size by Country (2017-2022)
    7.3 Europe Respiratory Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Respiratory Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Respiratory Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Respiratory Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Respiratory Drugs Market Size (2017-2028)
    9.2 Latin America Respiratory Drugs Market Size by Country (2017-2022)
    9.3 Latin America Respiratory Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Respiratory Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Respiratory Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Respiratory Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Allied Healthcare
        11.1.1 Allied Healthcare Company Detail
        11.1.2 Allied Healthcare Business Overview
        11.1.3 Allied Healthcare Respiratory Drugs Introduction
        11.1.4 Allied Healthcare Revenue in Respiratory Drugs Business (2017-2022)
        11.1.5 Allied Healthcare Recent Development
    11.2 Cardinal Health
        11.2.1 Cardinal Health Company Detail
        11.2.2 Cardinal Health Business Overview
        11.2.3 Cardinal Health Respiratory Drugs Introduction
        11.2.4 Cardinal Health Revenue in Respiratory Drugs Business (2017-2022)
        11.2.5 Cardinal Health Recent Development
    11.3 Medtronic
        11.3.1 Medtronic Company Detail
        11.3.2 Medtronic Business Overview
        11.3.3 Medtronic Respiratory Drugs Introduction
        11.3.4 Medtronic Revenue in Respiratory Drugs Business (2017-2022)
        11.3.5 Medtronic Recent Development
    11.4 Drager Medical
        11.4.1 Drager Medical Company Detail
        11.4.2 Drager Medical Business Overview
        11.4.3 Drager Medical Respiratory Drugs Introduction
        11.4.4 Drager Medical Revenue in Respiratory Drugs Business (2017-2022)
        11.4.5 Drager Medical Recent Development
    11.5 DeVilbiss Healthcare
        11.5.1 DeVilbiss Healthcare Company Detail
        11.5.2 DeVilbiss Healthcare Business Overview
        11.5.3 DeVilbiss Healthcare Respiratory Drugs Introduction
        11.5.4 DeVilbiss Healthcare Revenue in Respiratory Drugs Business (2017-2022)
        11.5.5 DeVilbiss Healthcare Recent Development
    11.6 Fisher & Paykel Healthcare
        11.6.1 Fisher & Paykel Healthcare Company Detail
        11.6.2 Fisher & Paykel Healthcare Business Overview
        11.6.3 Fisher & Paykel Healthcare Respiratory Drugs Introduction
        11.6.4 Fisher & Paykel Healthcare Revenue in Respiratory Drugs Business (2017-2022)
        11.6.5 Fisher & Paykel Healthcare Recent Development
    11.7 Getinge
        11.7.1 Getinge Company Detail
        11.7.2 Getinge Business Overview
        11.7.3 Getinge Respiratory Drugs Introduction
        11.7.4 Getinge Revenue in Respiratory Drugs Business (2017-2022)
        11.7.5 Getinge Recent Development
    11.8 Hamilton Medical
        11.8.1 Hamilton Medical Company Detail
        11.8.2 Hamilton Medical Business Overview
        11.8.3 Hamilton Medical Respiratory Drugs Introduction
        11.8.4 Hamilton Medical Revenue in Respiratory Drugs Business (2017-2022)
        11.8.5 Hamilton Medical Recent Development
    11.9 Invacare Corporation
        11.9.1 Invacare Corporation Company Detail
        11.9.2 Invacare Corporation Business Overview
        11.9.3 Invacare Corporation Respiratory Drugs Introduction
        11.9.4 Invacare Corporation Revenue in Respiratory Drugs Business (2017-2022)
        11.9.5 Invacare Corporation Recent Development
    11.10 nSpire Health
        11.10.1 nSpire Health Company Detail
        11.10.2 nSpire Health Business Overview
        11.10.3 nSpire Health Respiratory Drugs Introduction
        11.10.4 nSpire Health Revenue in Respiratory Drugs Business (2017-2022)
        11.10.5 nSpire Health Recent Development
    11.11 ResMed
        11.11.1 ResMed Company Detail
        11.11.2 ResMed Business Overview
        11.11.3 ResMed Respiratory Drugs Introduction
        11.11.4 ResMed Revenue in Respiratory Drugs Business (2017-2022)
        11.11.5 ResMed Recent Development
    11.12 Respironics
        11.12.1 Respironics Company Detail
        11.12.2 Respironics Business Overview
        11.12.3 Respironics Respiratory Drugs Introduction
        11.12.4 Respironics Revenue in Respiratory Drugs Business (2017-2022)
        11.12.5 Respironics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Respiratory Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Asthma
    Table 3. Key Players of Chronic Obstructive Pulmonary Disease
    Table 4. Key Players of Idiopathic Pulmonary Fibrosis
    Table 5. Key Players of Cystic Fibrosis
    Table 6. Global Respiratory Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Respiratory Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Respiratory Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Respiratory Drugs Market Share by Region (2017-2022)
    Table 10. Global Respiratory Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Respiratory Drugs Market Share by Region (2023-2028)
    Table 12. Respiratory Drugs Market Trends
    Table 13. Respiratory Drugs Market Drivers
    Table 14. Respiratory Drugs Market Challenges
    Table 15. Respiratory Drugs Market Restraints
    Table 16. Global Respiratory Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Respiratory Drugs Market Share by Players (2017-2022)
    Table 18. Global Top Respiratory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2021)
    Table 19. Ranking of Global Top Respiratory Drugs Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Respiratory Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Respiratory Drugs Product Solution and Service
    Table 23. Date of Enter into Respiratory Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Respiratory Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Respiratory Drugs Revenue Market Share by Type (2017-2022)
    Table 27. Global Respiratory Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Respiratory Drugs Revenue Market Share by Type (2023-2028)
    Table 29. Global Respiratory Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Respiratory Drugs Revenue Market Share by Application (2017-2022)
    Table 31. Global Respiratory Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Respiratory Drugs Revenue Market Share by Application (2023-2028)
    Table 33. North America Respiratory Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Respiratory Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Respiratory Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Respiratory Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Respiratory Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Respiratory Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Respiratory Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Respiratory Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Respiratory Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Respiratory Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Allied Healthcare Company Detail
    Table 44. Allied Healthcare Business Overview
    Table 45. Allied Healthcare Respiratory Drugs Product
    Table 46. Allied Healthcare Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 47. Allied Healthcare Recent Development
    Table 48. Cardinal Health Company Detail
    Table 49. Cardinal Health Business Overview
    Table 50. Cardinal Health Respiratory Drugs Product
    Table 51. Cardinal Health Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 52. Cardinal Health Recent Development
    Table 53. Medtronic Company Detail
    Table 54. Medtronic Business Overview
    Table 55. Medtronic Respiratory Drugs Product
    Table 56. Medtronic Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 57. Medtronic Recent Development
    Table 58. Drager Medical Company Detail
    Table 59. Drager Medical Business Overview
    Table 60. Drager Medical Respiratory Drugs Product
    Table 61. Drager Medical Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 62. Drager Medical Recent Development
    Table 63. DeVilbiss Healthcare Company Detail
    Table 64. DeVilbiss Healthcare Business Overview
    Table 65. DeVilbiss Healthcare Respiratory Drugs Product
    Table 66. DeVilbiss Healthcare Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 67. DeVilbiss Healthcare Recent Development
    Table 68. Fisher & Paykel Healthcare Company Detail
    Table 69. Fisher & Paykel Healthcare Business Overview
    Table 70. Fisher & Paykel Healthcare Respiratory Drugs Product
    Table 71. Fisher & Paykel Healthcare Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 72. Fisher & Paykel Healthcare Recent Development
    Table 73. Getinge Company Detail
    Table 74. Getinge Business Overview
    Table 75. Getinge Respiratory Drugs Product
    Table 76. Getinge Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 77. Getinge Recent Development
    Table 78. Hamilton Medical Company Detail
    Table 79. Hamilton Medical Business Overview
    Table 80. Hamilton Medical Respiratory Drugs Product
    Table 81. Hamilton Medical Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 82. Hamilton Medical Recent Development
    Table 83. Invacare Corporation Company Detail
    Table 84. Invacare Corporation Business Overview
    Table 85. Invacare Corporation Respiratory Drugs Product
    Table 86. Invacare Corporation Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 87. Invacare Corporation Recent Development
    Table 88. nSpire Health Company Detail
    Table 89. nSpire Health Business Overview
    Table 90. nSpire Health Respiratory Drugs Product
    Table 91. nSpire Health Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 92. nSpire Health Recent Development
    Table 93. ResMed Company Detail
    Table 94. ResMed Business Overview
    Table 95. ResMed Respiratory DrugsProduct
    Table 96. ResMed Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 97. ResMed Recent Development
    Table 98. Respironics Company Detail
    Table 99. Respironics Business Overview
    Table 100. Respironics Respiratory DrugsProduct
    Table 101. Respironics Revenue in Respiratory Drugs Business (2017-2022) & (US$ Million)
    Table 102. Respironics Recent Development
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Respiratory Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Asthma Features
    Figure 3. Chronic Obstructive Pulmonary Disease Features
    Figure 4. Idiopathic Pulmonary Fibrosis Features
    Figure 5. Cystic Fibrosis Features
    Figure 6. Global Respiratory Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Care Case Studies
    Figure 9. Others Case Studies
    Figure 10. Respiratory Drugs Report Years Considered
    Figure 11. Global Respiratory Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Respiratory Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Respiratory Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Respiratory Drugs Market Share by Players in 2021
    Figure 15. Global Top Respiratory Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Respiratory Drugs Revenue in 2021
    Figure 17. North America Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Respiratory Drugs Market Share by Country (2017-2028)
    Figure 19. United States Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Respiratory Drugs Market Share by Country (2017-2028)
    Figure 23. Germany Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Respiratory Drugs Market Share by Region (2017-2028)
    Figure 31. China Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Respiratory Drugs Market Share by Country (2017-2028)
    Figure 39. Mexico Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Respiratory Drugs Market Share by Country (2017-2028)
    Figure 43. Turkey Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Respiratory Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Allied Healthcare Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 46. Cardinal Health Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 47. Medtronic Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 48. Drager Medical Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 49. DeVilbiss Healthcare Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 50. Fisher & Paykel Healthcare Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 51. Getinge Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 52. Hamilton Medical Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 53. Invacare Corporation Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 54. nSpire Health Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 55. ResMed Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 56. Respironics Revenue Growth Rate in Respiratory Drugs Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allied Healthcare
Cardinal Health
Medtronic
Drager Medical
DeVilbiss Healthcare
Fisher & Paykel Healthcare
Getinge
Hamilton Medical
Invacare Corporation
nSpire Health
ResMed
Respironics
Frequently Asked Questions
Respiratory Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Respiratory Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Respiratory Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

RFID in Healthcare

RFID in Healthcare market is segmented by players, region (country), by Type and by Application.  ... Read More